Charles Paglione

Charles joined S2N Health as an Analyst in January 2020 following his time as a co-op in the Spring of 2019. Prior to joining S2N, he held positions at NxStage Medical and Acceleron Pharma. Charles graduated summa cum laude with a B.S. in Bioengineering and Biochemistry from Northeastern University.